Status:
COMPLETED
COVID-19 and SARS-CoV-2 Detection in Saliva
Lead Sponsor:
Ambry Genetics
Collaborating Sponsors:
The Saratoga Hospital
St. Joseph Hospital of Orange
Conditions:
RNA Virus Infections
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to validate the use of human saliva as a substrate for an assay to detect SARS-CoV-2 and define accuracy, analytical sensitivity and specificity of the TaqPath RT-PCR test.
Detailed Description
Investigators will carry out validation of a laboratory assay to detect SARS-CoV-2 nucleic acids in human saliva samples. Data for the validation will include the test results from standard nasopharyn...
Eligibility Criteria
Inclusion
- Reads and understands English or Spanish
- Willing and able to provide consent
- Diagnosed with COVID-19 or at high risk of disease based on objective criteria
Exclusion
- Unwilling or unable to provide consent.
- Pregnant female
Key Trial Info
Start Date :
May 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 5 2021
Estimated Enrollment :
67 Patients enrolled
Trial Details
Trial ID
NCT04517682
Start Date
May 21 2020
End Date
August 5 2021
Last Update
March 7 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ambry Genetics
Aliso Viejo, California, United States, 92656